Hematopoietic stem cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood or umbilical cord blood. It can be autologous (the patient's own stem cells are used), allogeneic (stem cells come from a donor) or syngeneic (from an identical twin). It is most often performed for patients with certain cancers of the blood or bone marrow, such as multiple myeloma or leukemia. In these cases, the recipient's immune system is usually destroyed by radiotherapy or chemotherapy before transplantation. Infection and graft versus host disease are major complications of allogenic GCSH. Hematopoietic stem cell transplantation remains a dangerous procedure with many possible complications; it is reserved for patients with fatal diseases. As survival after the procedure increased, its use has spread beyond cancer to autoimmune diseases and hereditary skeletal dysplasia; including infantile malignant osteopetrosis and mucopolysaccharidosis. Many recipients of GCSH are patients with multiple myeloma or leukemia who would not benefit from or are already resistant to long-term treatment with chemotherapy
Research Article: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Case Report: Journal of Blood & Lymph
Case Report: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Research Article: Journal of Blood & Lymph
Editorial: Journal of Blood & Lymph
Editorial: Journal of Blood & Lymph
Scientific Sessions&YRF: Cancer Science & Therapy
Scientific Sessions&YRF: Cancer Science & Therapy
Posters: Journal of Forensic Research
Posters: Journal of Forensic Research
Scientific Tracks Abstracts: Journal of Bioengineering & Biomedical Science
Scientific Tracks Abstracts: Journal of Bioengineering & Biomedical Science
Scientific Tracks Abstracts: Journal of Health & Medical Informatics
Scientific Tracks Abstracts: Journal of Health & Medical Informatics
Posters & Accepted Abstracts: Journal of Nephrology & Therapeutics
Posters & Accepted Abstracts: Journal of Nephrology & Therapeutics
Journal of Blood & Lymph received 443 citations as per Google Scholar report